AllergoEye System

Artificial intelligence-driven diagnostic system that analyzes visual field test data to detect glaucomatous changes and assess disease progression. The platform automatically interprets test results and provides clinical assessment outputs for ophthalmologists.

AI-based diagnostic system for glaucoma detection through optic nerve assessment from fundus images. Identifies suspected glaucomatous changes with high precision in approximately 30 seconds. Currently in planned development phase.

A cloud-based, AI-powered online visual field testing platform for glaucoma detection and monitoring. The platform enables hospital-grade visual field testing on standard computers or tablets without requiring specialized hardware. It uses AI webcam monitoring to track head position and gaze, generates detailed visual field maps comparing sensitivity to age-matched normal data, and is accessible via web browsers for convenient testing in clinical and remote settings.

All in One Tearscope system for non-invasive diagnosis and comprehensive evaluation of dry eye disease. Integrates EASYTEAR VIEW+ and HDWcam imaging technology to assess lacrimal condition and tear film characteristics in clinical settings.

AI-powered platform for early detection of retinal changes and chronic eye disease via fundus imaging analysis. Enables rapid, non-invasive screening for diabetic retinopathy and other retinal pathology by analyzing fundus photographs. Supports preventive ophthalmology and patient risk stratification in primary care and community settings.

Integrated ocular surface evaluation and treatment device for dry eye syndrome diagnosis. Combines diagnostic imaging with therapeutic capabilities. Automated analysis for standardized dry eye assessment.

AI-powered platform that analyzes retinal images to identify early signs of eye diseases and assess cardiovascular disease risk. The system provides standardized risk assessment reporting to support clinical decision-making and reduce missed diagnoses.

A comprehensive portable eye screening kit that combines multiple handheld devices for point-of-care eye health assessment. The kit integrates on-the-edge AI retinal imaging capabilities for non-invasive evaluation of systemic and retinal health.

Specialized optical imaging systems for comprehensive ophthalmic diagnosis and monitoring of ocular diseases and conditions.

AIRDOC is an AI-powered retinal imaging system that performs automated screening and assessment of systemic disease risk markers. The device analyzes retinal photographs to detect diabetic retinopathy, hypertension indicators, and cardiovascular risk factors, enabling early intervention in primary care and screening programs.

All-in-one tearscope system for non-invasive assessment and diagnosis of dry eye disease. Combines imaging and software analysis to evaluate tear film quality, quantity, and ocular surface condition in a single diagnostic platform.

AI-powered diagnostic system for automated assessment of diabetic retinopathy from retinal fundus images. Delivers high-precision screening results in under 60 seconds with high sensitivity and low false-positive rates. Certified as Class IIb EU-MDR medical device since May 2023.